Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

Nurix Therapeutics, Inc. Filed Acc 0000902664-26-004581

Stakes reported in this filing

Reporting person Shares Of the class
Vestal Point Capital, LP 7,025,000 6.4%
Ryan Wilder 7,025,000 6.4%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…